Comments on: InnoCentive Seeker Spotlight: TB Alliance Works to Eradicate One of the World’s Deadliest Diseases http://blog.innocentive.com/2008/12/04/innocentive-seeker-spotlight-tb-alliance-works-to-eradicate-one-of-the-worlds-deadliest-diseases/ Highlighting Global Open Innovation Wed, 08 Feb 2012 21:56:18 -0500 http://wordpress.org/?v=2.8.4 hourly 1 By: Perspectives on Innovation » Blog Archive » America Competes Act – the US Government enables a fresh approach to innovation http://blog.innocentive.com/2008/12/04/innocentive-seeker-spotlight-tb-alliance-works-to-eradicate-one-of-the-worlds-deadliest-diseases/comment-page-1/#comment-121577 Perspectives on Innovation » Blog Archive » America Competes Act – the US Government enables a fresh approach to innovation Tue, 18 Jan 2011 18:46:31 +0000 http://blog.innocentive.com/?p=147#comment-121577 [...] to lighting, internet capabilities and malaria control to remote villages. We partnered with the  Global Alliance for Tuberculosis in 2009 and improved the manufacturing processes for pending new therapies. We partnered with NASA [...] [...] to lighting, internet capabilities and malaria control to remote villages. We partnered with the  Global Alliance for Tuberculosis in 2009 and improved the manufacturing processes for pending new therapies. We partnered with NASA [...]

]]> By: Heartburn Home Remedy http://blog.innocentive.com/2008/12/04/innocentive-seeker-spotlight-tb-alliance-works-to-eradicate-one-of-the-worlds-deadliest-diseases/comment-page-1/#comment-8498 Heartburn Home Remedy Wed, 15 Apr 2009 12:48:50 +0000 http://blog.innocentive.com/?p=147#comment-8498 Not that I'm impressed a lot, but this is more than I expected for when I stumpled upon a link on Delicious telling that the info is awesome. Thanks. Not that I’m impressed a lot, but this is more than I expected for when I stumpled upon a link on Delicious telling that the info is awesome. Thanks.

]]> By: sameer http://blog.innocentive.com/2008/12/04/innocentive-seeker-spotlight-tb-alliance-works-to-eradicate-one-of-the-worlds-deadliest-diseases/comment-page-1/#comment-4072 sameer Wed, 31 Dec 2008 03:38:51 +0000 http://blog.innocentive.com/?p=147#comment-4072 This is indeed great achivement ; even the solver of this challange is significant. This platform could be used for development of low cost medicines for developing countries. This is indeed great achivement ; even the solver of this challange is
significant. This platform could be used for development of low cost
medicines for developing countries.

]]> By: D.A. http://blog.innocentive.com/2008/12/04/innocentive-seeker-spotlight-tb-alliance-works-to-eradicate-one-of-the-worlds-deadliest-diseases/comment-page-1/#comment-3424 D.A. Tue, 16 Dec 2008 17:56:22 +0000 http://blog.innocentive.com/?p=147#comment-3424 Yvonne, More efficient, methods of manufacturing the drug will not <i>directly</i> improve compliance. I don’t believe Dr. Kaneko implied a direct connection. It is improved, shorter treatment regimens that should improve compliance, by making it less burdensome for patients to complete treatments. The TB Alliance is committed to developing improved TB drugs, and ultimately improved TB treatment regimens. The organization is also committed to ensuring that any projects it develops will be affordable, adopted, and available to those who need them. Improved manufacturing processes theoretically represent benefits/savings that can be passed on to patients in the future. In the big picture, there is a syllogistic connection between improved manufacturing processes and increased rates of compliance. Improved treatment regimens only translate to improved treatment outcomes (improved rates of compliance) if they are affordable, adopted, and available. Affordability, adoption, and availability are prerequisites to a superior treatment actually being able to deliver its benefits, “on the ground.” By improving the efficiency of the manufacturing process one can reduce barriers to affordability, adoption, and availability, So, theoretically, there is a connection, but there are many other factors and steps in between. Yvonne,

More efficient, methods of manufacturing the drug will not directly improve compliance. I don’t believe Dr. Kaneko implied a direct connection. It is improved, shorter treatment regimens that should improve compliance, by making it less burdensome for patients to complete treatments.

The TB Alliance is committed to developing improved TB drugs, and ultimately improved TB treatment regimens. The organization is also committed to ensuring that any projects it develops will be affordable, adopted, and available to those who need them. Improved manufacturing processes theoretically represent benefits/savings that can be passed on to patients in the future.

In the big picture, there is a syllogistic connection between improved manufacturing processes and increased rates of compliance.

Improved treatment regimens only translate to improved treatment outcomes (improved rates of compliance) if they are affordable, adopted, and available. Affordability, adoption, and availability are prerequisites to a superior treatment actually being able to deliver its benefits, “on the ground.” By improving the efficiency of the manufacturing process one can reduce barriers to affordability, adoption, and availability,

So, theoretically, there is a connection, but there are many other factors and steps in between.

]]> By: Yvonne Boyer http://blog.innocentive.com/2008/12/04/innocentive-seeker-spotlight-tb-alliance-works-to-eradicate-one-of-the-worlds-deadliest-diseases/comment-page-1/#comment-2877 Yvonne Boyer Fri, 05 Dec 2008 15:20:45 +0000 http://blog.innocentive.com/?p=147#comment-2877 Although I understand the need for manufacturing these kinds of drugs in a more cost efficient manner, I do not understanda how this will improve compliance. Can someone explain this to me? thanks Although I understand the need for manufacturing these kinds of drugs in a more cost efficient manner, I do not understanda how this will improve compliance. Can someone explain this to me?
thanks

]]>